Exact Mass: 406.114
Exact Mass Matches: 406.114
Found 70 metabolites which its exact mass value is equals to given mass value 406.114,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rotenonone
2-(4-Chloro-3,5-dimethylphenoxy)-N-(2-phenyl-2H-benzotriazol-5-yl)-acetamide
Tasquinimod
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
6-oxo-6a,12a-dehydrodeguelin|9,10-dimethoxy-3,3-dimethyl-3H-pyrano[2,3-c;6,5-f] dichromium ene-7,13-dione|9,10-Dimethoxy-3,3-dimethyl-3H-pyrano[2,3-c;6,5-f]dichromen-7,13-dion|villosinol
3,4-dihydro-7-hydroxy-4-(3,4-dihydroxyphenyl)-5-[(1E)-2-(3,4-dihydroxyphenyl)ethenyl]-2H-1-benzopyran-2-one|gnetumontanin F
floctafenine
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
4-METHYLUMBELLIFERYL-BETA-D-GLUCURONIDE TRIHYDRATE
(2R)-4-[5-Chloro-2-[(4-methoxyphenyl)thio]phenyl]-2-methyl-1-piperazineacetic acid
1-PYRROLIDIN-2-(3,5-DICHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE
Penamecillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
N-[5-(diethylamino)-2-[(3,5-dinitro-2-thienyl)azo]phenyl]acetamide
N-(PIPERIDIN-4-YL)-1-TOSYL-1H-BENZO[D]IMIDAZOL-2-AMINE HYDROCHLORIDE
13-(2-CHLORO-PHENYL)-3,3-DIMETHYL-2,3,4,13-TETRAHYDRO-INDAZOLO[1,2-B]PHTHALAZINE-1,6,11-TRIONE
13-(4-chlorophenyl)-3,3-dimethyl-4,13-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11-trione
SR 2640 hydrochloride,2-[[3-(2-Quinolinylmethoxy)phenyl]amino]benzoicacidhydrochloride
(R)-Lip-L-glu-L-ala-OH
CMX-2043 is a novel analogue of α-Lipoic Acid (HY-N0492). CMX-2043 is effective in antioxidant effect, activation of insulin receptor kinase, soluble tyrosine kinase, and Akt phosphorylation. CMX-2043 shows protection against ischemia-reperfusion injury (IRI) in rat model[1][2]. CMX-2043 is a novel analogue of α-Lipoic Acid (HY-N0492). CMX-2043 is effective in antioxidant effect, activation of insulin receptor kinase, soluble tyrosine kinase, and Akt phosphorylation. CMX-2043 shows protection against ischemia-reperfusion injury (IRI) in rat model[1][2].
1H-Indole-3-carboxylic acid, 1-(((4-methylphenyl)amino)carbonyl)-2-hydroxy-6-(trifluoromethyl)-, ethyl ester
2,3-Dicarboxy-4-(2-chloro-phenyl)-1-ethyl-5-isopropoxycarbonyl-6-methyl-pyridinium
6,7,8-Trimethoxy-2-(2-phenoxypyridin-3-yl)-3,1-benzoxazin-4-one
N-[(2-chlorophenyl)methyl]-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide
N-(2,4-dimethoxyphenyl)-3-(2-furoylamino)-1-benzofuran-2-carboxamide
3-methyl-N-(1-oxo-2-phenoxyethyl)-1-phenyl-5-thieno[2,3-c]pyrazolecarbohydrazide
3-(2,4-Dichlorophenoxy)-1-(2,3-dimethylphenyl)-4-(propylaminomethyl)-2-azetidinone
[(2R,3S,4R,5R)-5-[2-(dimethylamino)-7-methyl-6-oxo-1H-purin-9-ium-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
CGS 7181
LY266097 (hydrochloride)
LY266097 hydrochloride is a selective 5-HT2B receptor antagonist with pKis of 7.7, 9.8, and 7.6 for 5-HT2A, 5-HT2B, 5-HT2C, respectively. 5-HT2B receptor blockade contributes to the research in depression[1].
WAY-354574
WAY-354574 is an active molecule targeting deacetylase (Sirtuin) for the study of Huntington's disease (HD)[1].
